Open an account

Bioceres Crop Solutions

BIOX · NASDAQ

$0.2518−$0.0033 (−1.29%)TodayMarket closed ·
Prev close $0.2551

About BIOX

Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. Its segments include Seed and integrated products, Crop protection and Crop nutrition. Seed and integrated products segment focuses on the development and commercialization of seed technologies and products, including provision of seed technologies integrated with crop protection and crop nutrition products designed to control weeds, insects or diseases, to increase their quality characteristics. Crop protection segment includes the development, production and marketing of adjuvants and a range of pest control molecules and biocontrol products. Crop nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops, and of fertilizers, including biofertilizers and micro-granulated fertilizers that optimize the productivity and yield of the crops.

Employees
751
Headquarters
Rosario, Santa Fe
Listed
Mar 22, 2018
Sector
Materials
Industry
Chemicals
Website
biocerescrops.com

BIOX key statistics

Market cap
15.92M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
203.68K
Volume
226.90K
Open price
$0.26
High today
$0.26
Low today
$0.2401
52 Week high
$2.19
52 Week low
$0.2526

Bioceres Crop Solutions (BIOX) at a glance

As of Oct 20, 2026, Bioceres Crop Solutions (BIOX) shares are priced at $0.2518, giving the company a market cap of 15.92M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.2401 and $0.26. The current price is 4.9% above the day's low and 3.2% below its high.

Volume so far is 226.90K shares, in line with the average of 203.68K shares a day.

Over the past year Bioceres Crop Solutions has ranged from $0.2526 to $2.19, and now sits 0% of the way up that range.

Bioceres Crop Solutions met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q3 FY26 it reported -$0.16 per share against an estimate of -$0.051.

The average analyst price target is $2.04, 710.2% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 1 analyst rating say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 3 analystsAvg $2.04
Low
$2.02
Now
$0.2518
High
$2.10

BIOX earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 8 quarters, by 86.9% on average.

  1. Q4 FY24: reported -$0.03 per share against an estimate of $0.2489
  2. Q1 FY25: reported -$0.09 per share against an estimate of -$0.0077
  3. Q2 FY25: reported $0.009 per share against an estimate of $0.0884
  4. Q3 FY25: reported -$0.02 per share against an estimate of -$0.153
  5. Q4 FY25: reported -$0.70 per share against an estimate of $0.0765
  6. Q2 FY26: reported -$0.08 per share against an estimate of $0.0714
  7. Q1 FY26: reported -$0.16 per share against an estimate of -$0.051
  8. Q3 FY26: reported -$0.16 per share against an estimate of -$0.051

BIOX news

  • Press releaseBusiness Wire

    Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results

  • Press releaseBusiness Wire

    Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time

  • Press releaseBusiness Wire

    Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results

  • Press releaseBusiness Wire

    CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

  • Press releaseBusiness Wire

    Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

  • Press releaseBusiness Wire

    A Message from Our Chief Executive Officer

  • Press releaseBusiness Wire

    Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

  • Press releaseBusiness Wire

    Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.